Trial Profile
A phase I open label, single ascending dose trial of recilisib (EX-RAD, ON 01210.Na) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Recilisib (Primary)
- Indications Acute radiation syndrome
- Focus Adverse reactions
- 14 Apr 2015 New trial record